BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23580429)

  • 1. Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues.
    Neubauer D; Aumayr M; Gösler I; Skern T
    J Gen Virol; 2013 Jul; 94(Pt 7):1535-1546. PubMed ID: 23580429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining residues involved in human rhinovirus 2A proteinase substrate recognition.
    Sousa C; Schmid EM; Skern T
    FEBS Lett; 2006 Oct; 580(24):5713-7. PubMed ID: 17007846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate requirements of a human rhinoviral 2A proteinase.
    Skern T; Sommergruber W; Auer H; Volkmann P; Zorn M; Liebig HD; Fessl F; Blaas D; Kuechler E
    Virology; 1991 Mar; 181(1):46-54. PubMed ID: 1847268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A.
    Sommergruber W; Ahorn H; Zöphel A; Maurer-Fogy I; Fessl F; Schnorrenberg G; Liebig HD; Blaas D; Kuechler E; Skern T
    J Biol Chem; 1992 Nov; 267(31):22639-44. PubMed ID: 1331062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recognition sequence of coxsackievirus 2A proteinase.
    Muto S; Miyoshi H; Nishikawa H; Nakashima H
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1436-42. PubMed ID: 16930558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of in vitro peptide substrates for human rhinovirus-14 2A protease.
    Wang QM; Johnson RB; Sommergruber W; Shepherd TA
    Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions.
    Lu HH; Li X; Cuconati A; Wimmer E
    J Virol; 1995 Dec; 69(12):7445-52. PubMed ID: 7494250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the potyviral HC-pro autoproteolytic cleavage site.
    Carrington JC; Herndon KL
    Virology; 1992 Mar; 187(1):308-15. PubMed ID: 1736533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.
    Baxter NJ; Roetzer A; Liebig HD; Sedelnikova SE; Hounslow AM; Skern T; Waltho JP
    J Virol; 2006 Feb; 80(3):1451-62. PubMed ID: 16415022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases.
    Deszcz L; Cencic R; Sousa C; Kuechler E; Skern T
    J Virol; 2006 Oct; 80(19):9619-27. PubMed ID: 16973565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Aumayr M; Schrempf A; Üzülmez Ö; Olek KM; Skern T
    Virology; 2017 Nov; 511():123-134. PubMed ID: 28843814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analyses support a model for the HRV2 2A proteinase.
    Sommergruber W; Seipelt J; Fessl F; Skern T; Liebig HD; Casari G
    Virology; 1997 Aug; 234(2):203-14. PubMed ID: 9268151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk.
    Deutschmann-Olek KM; Yue WW; Bezerra GA; Skern T
    Virology; 2021 Oct; 562():128-141. PubMed ID: 34315103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc.
    Glaser W; Triendl A; Skern T
    J Virol; 2003 Apr; 77(8):5021-5. PubMed ID: 12663811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage.
    Li X; Lu HH; Mueller S; Wimmer E
    J Gen Virol; 2001 Feb; 82(Pt 2):397-408. PubMed ID: 11161279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
    Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif.
    Sommergruber W; Ahorn H; Klump H; Seipelt J; Zoephel A; Fessl F; Krystek E; Blaas D; Kuechler E; Liebig HD
    Virology; 1994 Feb; 198(2):741-5. PubMed ID: 8291255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase.
    Long AC; Orr DC; Cameron JM; Dunn BM; Kay J
    FEBS Lett; 1989 Nov; 258(1):75-8. PubMed ID: 2556299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of substrate recognition by poliovirus 2A proteinase.
    Hellen CU; Lee CK; Wimmer E
    J Virol; 1992 Jun; 66(6):3330-8. PubMed ID: 1316450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.